See more : Space Group Holdings Limited (2448.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Agra Ventures Ltd. (AGFAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Agra Ventures Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Hiscox Ltd (HCXLF) Income Statement Analysis – Financial Results
- Intellia Therapeutics, Inc. (NTLA) Income Statement Analysis – Financial Results
- Aasen Sparebank (AASB.OL) Income Statement Analysis – Financial Results
- PT Kino Indonesia Tbk (KINO.JK) Income Statement Analysis – Financial Results
- Indian Bank (INDIANB.BO) Income Statement Analysis – Financial Results
Agra Ventures Ltd. (AGFAF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://agraventures.com
About Agra Ventures Ltd.
Agra Ventures Ltd. operates in the cannabis industry in Canada and Germany. The company engages in the cultivation, distribution, and marketing of high-quality cannabis and cannabis-infused products. It manufactures, processes, and distributes soft gels, tinctures, distillates, and THC oils, as well as edibles, cosmetics, beverages, CBD performance, and pet products. The company was formerly known as AgraFlora Organics International Inc. and changed its name to Agra Ventures Ltd. in July 2021. Agra Ventures Ltd. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 673.42K | 928.21K | 1.49M | 3.89K | 0.00 | 0.00 | 138.85K | 9.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 369.45K | 551.18K | 1.26M | 13.00K | 12.82K | 3.94K | 137.23K | 10.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 83.87K | 0.00 |
Gross Profit | 0.00 | 303.97K | 377.03K | 233.82K | -9.11K | -12.82K | -3.94K | 1.62K | -1.96K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -83.87K | 0.00 |
Gross Profit Ratio | 0.00% | 45.14% | 40.62% | 15.68% | -234.26% | 0.00% | 0.00% | 1.17% | -21.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 1.41K | 36.40K | 394.95K | 452.68K | 84.56K | 70.90K | 210.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 48.58K | 0.00 |
General & Administrative | 942.53K | 2.19M | 5.06M | 22.87M | 56.27M | 6.27M | 2.59M | 985.96K | 1.06M | 1.19M | 362.80K | 428.48K | 795.20K | 414.90K | 283.50K | 1.54M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 37.92K | 47.80K | 1.70K | -15.74K | 4.08M | 153.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.15M | 2.19M | 5.06M | 22.85M | 56.27M | 6.27M | 2.59M | 985.96K | 1.06M | 1.19M | 362.80K | 428.48K | 795.20K | 414.90K | 283.50K | 1.54M | 1.40M | 535.52K | 285.69K |
Other Expenses | 0.00 | 300.00K | 557.38K | -559.57K | 17.54K | 129.95K | 0.00 | 13.00K | 3.10K | 188.00 | 0.00 | 104.93K | 134.75K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 1.15M | 20.40M | 5.66M | 24.35M | 57.29M | 6.37M | 2.67M | 1.38M | 1.22M | 1.19M | 362.80K | 428.48K | 795.20K | 414.90K | 283.50K | 1.64M | 1.47M | 589.88K | 286.40K |
Cost & Expenses | 1.15M | 20.77M | 6.21M | 25.60M | 57.31M | 6.37M | 2.67M | 1.52M | 1.23M | 1.19M | 362.80K | 428.48K | 795.20K | 414.90K | 283.50K | 1.64M | 1.47M | 673.75K | 286.40K |
Interest Income | 2.28M | 657.65K | 649.79K | 101.67K | 32.75K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.86K | 0.00 | 5.75K | 0.00 |
Interest Expense | 0.00 | 3.34M | 6.63M | 5.73M | 212.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 621.00 | 327.00 |
Depreciation & Amortization | 106.00K | 145.24K | 368.72K | 1.02M | 151.48K | 12.82K | 3.94K | 186.89K | 158.27K | 1.62M | 899.11K | 0.00 | 0.00 | 0.00 | 0.00 | 24.02K | 17.93K | 5.77K | 709.00 |
EBITDA | -1.05M | -16.88M | -7.87M | -28.28M | -59.34M | -5.42M | -2.16M | -1.11M | -1.07M | 491.55K | 1.26M | -428.48K | -929.95K | -414.90K | -283.50K | 4.19M | -1.46M | -667.98K | -285.69K |
EBITDA Ratio | 0.00% | -2,820.83% | -847.55% | -1,896.06% | -1,526,153.19% | 0.00% | 0.00% | -523.30% | -7,430.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -1.15M | -19.14M | -8.24M | -29.30M | -59.49M | -6.82M | -3.40M | -913.50K | -827.61K | -1.24M | 362.80K | -428.48K | -929.95K | -414.90K | -283.50K | 4.17M | -1.47M | 673.75K | 286.40K |
Operating Income Ratio | 0.00% | -2,842.44% | -887.27% | -1,964.39% | -1,530,049.20% | 0.00% | 0.00% | -657.90% | -9,187.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 15.76M | -18.12M | 7.02M | -84.97M | -44.39M | -396.10K | 39.39K | -931.67K | -222.77K | -13.31K | -1.65M | 104.93K | 134.75K | -129.85K | 19.38K | -5.81M | 9.32K | -1.34M | -573.32K |
Income Before Tax | 14.60M | -20.03M | -2.41M | -103.20M | -101.69M | -5.82M | -2.12M | -2.04M | -1.45M | -1.15M | -1.99M | -323.55K | -660.44K | -544.75K | -264.13K | -1.64M | -1.46M | -668.58K | -286.93K |
Income Before Tax Ratio | 0.00% | -2,974.48% | -260.04% | -6,918.60% | -2,615,513.61% | 0.00% | 0.00% | -1,470.45% | -16,056.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 25.54M | 5.70M | 88.67K | -2.71M | -528.04K | -809.49K | 467.74K | 396.02K | -1.67M | 725.60K | 0.00 | 11.82K | 0.00 | -418.23K | 5.81M | -75.31K | -5.13K | -34.69K |
Net Income | 17.77M | -41.93M | -5.10M | -102.86M | -100.98M | -5.74M | -2.04M | -2.04M | -1.45M | -1.15M | -1.99M | -323.55K | -672.26K | -544.75K | 418.23K | -7.45M | -1.46M | -668.58K | -252.23K |
Net Income Ratio | 0.00% | -6,227.17% | -548.98% | -6,895.34% | -2,597,249.67% | 0.00% | 0.00% | -1,470.45% | -16,056.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.87 | -19.72 | -10.71 | -294.79 | -581.53 | -70.73 | -35.46 | -53.12 | -79.05 | -155.41 | -784.34 | -163.91 | -450.28 | -473.69 | 0.20 | -4.68K | -1.36K | -776.51 | -320.09 |
EPS Diluted | 1.06 | -19.72 | -10.71 | -294.79 | -581.53 | -70.73 | -35.46 | -53.12 | -79.05 | -155.41 | -784.34 | -163.91 | -450.28 | -473.69 | 0.20 | -4.68K | -1.36K | -776.51 | -320.09 |
Weighted Avg Shares Out | 16.81M | 2.13M | 475.77K | 348.92K | 173.65K | 81.17K | 57.52K | 38.44K | 18.30K | 7.38K | 2.53K | 1.97K | 1.49K | 1.15K | 2.38K | 1.59K | 1.08K | 861.00 | 788.00 |
Weighted Avg Shares Out (Dil) | 13.77M | 2.13M | 475.77K | 348.92K | 173.65K | 81.17K | 57.52K | 38.44K | 18.30K | 7.38K | 2.53K | 1.97K | 1.49K | 1.15K | 2.38K | 1.59K | 1.08K | 861.00 | 788.00 |
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction
Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures
Digicann Ventures Grants Restricted Share Units
Digicann Ventures Announces Granting of Forbearance for Convertible Debenture Maturity Date
Digicann Ventures Repurchases $14,218,000 of Convertible Debentures for $1,600,000 in Cash
Digicann Ventures Announces Receipt of Last Portion of Final Earnout Milestone Payment
Digicann Ventures Grants Restricted Share Units
Digicann Ventures Announces Sale of Investment
CSE Bulletin: Name and Symbol Change and Consolidation - Agra Ventures Ltd. (AGRA)
Source: https://incomestatements.info
Category: Stock Reports